- DEPO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $11.9 million.
- DEPO has traded 14,603 shares today.
- DEPO is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in DEPO with the Ticky from Trade-Ideas. See the FREE profile for DEPO NOW at Trade-Ideas More details on DEPO: Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other conditions, and diseases of the central nervous system in the United States. DEPO has a PE ratio of 11.7. Currently there are 2 analysts that rate DepoMed a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for DepoMed has been 948,400 shares per day over the past 30 days. DepoMed has a market cap of $942.2 million and is part of the health care sector and drugs industry. The stock has a beta of 1.88 and a short float of 13.1% with 10.54 days to cover. Shares are up 51.6% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.